Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,086.00    -36.00 (-1.70%)
Bid:
2,080.00
Ask:
2,084.00
Spread: 4.00 (0.192%)
Market Cap: £3.50b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Update on Catalyst Technologies sale

23 Feb 2026 07:00

RNS Number : 9927T
Johnson Matthey PLC
23 February 2026
Β 

23rd February 2026

Β 

Johnson Matthey Plc

(the Company)

Β 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Transaction update

On 22nd May 2025, Johnson Matthey Plc ("JM") and Honeywell International, Inc. ("Honeywell") announced an agreement to sell JM's Catalyst Technologies business ("CT") to Honeywell (the "Transaction").

JM and Honeywell have agreed to extend the long stop date for satisfaction of the closing conditions (the "Long Stop Date") from 21st February to 21st July 2026. In the event that the only remaining antitrust approval condition is not satisfied by the Long Stop Date, the Long Stop Date may be further extended to 21st August 2026, if certain conditions are met. JM and Honeywell expect to complete the Transaction by the end of August 2026.

In agreeing to extend the Long Stop Date, JM and Honeywell have also agreed to amend the financial terms of the Transaction to reflect CT's business performance during 2025/26, which includes the deferral of key sustainable solutions licensing projects and reduced profitability from the supply of catalysts due to the challenging market environment. Accordingly, JM has agreed to sell the CT business to Honeywell for an enterprise value of Β£1,325 million on a cash and debt-free basis.

Consequently, JM now expects to return c.Β£1,000 million of net sale proceeds to its shareholders following completion of the Transaction, comprising Β£800 million through a special dividend with share consolidation, and Β£200 million through an on-market share buyback programme.

JM continues to make good progress on the implementation of its new cash-focused business model and is on track to deliver 2025/26 performance in line with guidance. This includes group underlying operating profit growth at the higher end of a mid single digit percentage rangeΒΉ, and positive free cash flow that is materially higher than last yearΒ².

The person responsible for the release of this announcement is Simon Price, General Counsel and Company Secretary of JM.

ENDS

Β 

Enquiries:Β 

Investor Relations

Β 

Β 

Louise Curran

Head of Investor Relations

+44 20 7269 8235

Media

Sinead Keller

Guy BatesΒ 

Group External Relations Director

Kekst CNC

+44 20 7269 8218

+44 7581 056 415

Β 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered inΒ EnglandΒ &Β WalesΒ number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

Β 

Notes:

1.

Underlying operating profit is on a pro forma basis excluding CT and Value Businesses, and at constant precious metal prices and constant currency.Β 

2.

Free cash flow defined as net cash flow from operating activities (excluding disposal related costs) after net interest paid, net purchases of non-current assets and investments and the principal elements of lease payments, adjusted to reflect the classification of Catalyst Technologies as a discontinued operation. 2024/25: Β£64 million inflow.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FURXLLLLQLLEBBF
Date   Source Headline
17th Jul 20257:00 amRNSAppointment of Andrew Cosslett as Chair
9th Jul 20254:48 pmRNSHolding(s) in Company
8th Jul 20259:55 amRNSHolding(s) in Company
1st Jul 20257:00 amRNSHolding(s) in Company
23rd Jun 20253:51 pmRNSHolding(s) in Company
20th Jun 20253:28 pmRNSDirector/PDMR Shareholding
17th Jun 20254:41 pmRNSHolding(s) in Company
12th Jun 20259:00 amRNSAnnual Financial Report - Part 2
11th Jun 20253:50 pmRNSHolding(s) in Company
6th Jun 20254:10 pmRNSHolding(s) in Company
5th Jun 20251:28 pmRNSHolding(s) in Company
4th Jun 20254:38 pmRNSHolding(s) in Company
30th May 20253:38 pmRNSHolding(s) in Company
28th May 20252:46 pmRNSHolding(s) in Company
27th May 20254:36 pmRNSHolding(s) in Company
27th May 20254:24 pmRNSHolding(s) in Company
27th May 20257:01 amRNSHolding(s) in Company
27th May 20257:00 amRNSHolding(s) in Company
22nd May 20255:09 pmRNSDirector/PDMR Shareholding
22nd May 20254:38 pmRNSHolding(s) in Company
22nd May 20257:01 amRNSJohnson Matthey Full Year Results
22nd May 20257:00 amRNSAgreement to sell Catalyst Technologies business
20th May 202510:35 amRNSHolding(s) in Company
19th May 20254:15 pmRNSHolding(s) in Company
19th May 20257:00 amRNSHolding(s) in Company
15th May 20255:53 pmRNSHolding(s) in Company
25th Apr 20252:43 pmRNSHolding(s) in Company
24th Apr 20253:28 pmRNSHolding(s) in Company
24th Apr 20258:00 amRNSHolding(s) in Company
17th Apr 20253:35 pmRNSDirector/PDMR Shareholding
26th Mar 20253:46 pmRNSHolding(s) in Company
25th Mar 20254:50 pmRNSHolding(s) in Company
24th Mar 20253:08 pmRNSHolding(s) in Company
21st Mar 20254:41 pmRNSHolding(s) in Company
20th Mar 202512:24 pmRNSDirector/PDMR Shareholding
14th Mar 20254:24 pmRNSHolding(s) in Company
13th Mar 20254:47 pmRNSHolding(s) in Company
12th Mar 20254:11 pmRNSHolding(s) in Company
11th Mar 20254:38 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSHolding(s) in Company
6th Mar 20255:18 pmRNSHolding(s) in Company
5th Mar 20257:00 amRNSHolding(s) in Company
4th Mar 20254:56 pmRNSHolding(s) in Company
3rd Mar 20255:12 pmRNSHolding(s) in Company
24th Feb 20255:08 pmRNSHolding(s) in Company
21st Feb 20253:40 pmRNSHolding(s) in Company
20th Feb 20252:46 pmRNSHolding(s) in Company
20th Feb 202510:57 amRNSDirector/PDMR Shareholding
19th Feb 20252:24 pmRNSHolding(s) in Company
13th Feb 20254:35 pmRNSDirector/PDMR Shareholding - replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.